News - Page 12 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Psychedelic Funding, Public Markets, and M&A in 2024

Psychedelic Funding, Public Markets, and M&A in 2024

Post published:February 12, 2025
Post category:2024 Year in Review Analysis

Read more about the article Ketamine on the Edge: Mindbloom’s At-Home Injections Spark Debate; UK Eyes Tougher Laws; DEA to Regulate Telehealth Prescribing; Spravato Sales Top $1bn

Ketamine on the Edge: Mindbloom’s At-Home Injections Spark Debate; UK Eyes Tougher Laws; DEA to Regulate Telehealth Prescribing; Spravato Sales Top $1bn

Post published:February 10, 2025
Post category:Analysis News Pα+

Read more about the article Pα+ Psychedelic Bulletin #187: NYT Article Reignites MDMA Rejection Blame Game; FDA “Wanted to Approve” MDMA, MindMed Exec Says; GH’s Data and RFK Jr. Confirmation Send Psychedelics Stocks Soaring

Pα+ Psychedelic Bulletin #187: NYT Article Reignites MDMA Rejection Blame Game; FDA “Wanted to Approve” MDMA, MindMed Exec Says; GH’s Data and RFK Jr. Confirmation Send Psychedelics Stocks Soaring

Post published:February 7, 2025
Post category:Psychedelic Bulletin Pα+

Read more about the article GH Research Reports Strong Phase 2b Results for 5-MeO-DMT in Treatment-Resistant Depression

GH Research Reports Strong Phase 2b Results for 5-MeO-DMT in Treatment-Resistant Depression

Post published:February 3, 2025
Post category:Analysis News Pα+

Read more about the article 2025’s Psychedelic Policy Surge: A State-by-State, Bill-by-Bill Analysis

2025’s Psychedelic Policy Surge: A State-by-State, Bill-by-Bill Analysis

Post published:January 31, 2025
Post category:Analysis News Pα+

Read more about the article The Psychedelic News Feed: September 2, 2024 – December 29, 2024

The Psychedelic News Feed: September 2, 2024 – December 29, 2024

Post published:January 30, 2025
Post category:Psychedelic News Feed Archive

Read more about the article Psychedelic Drug Development Pipeline Updates (Q1’25)

Psychedelic Drug Development Pipeline Updates (Q1’25)

Post published:January 30, 2025
Post category:2024 Year in Review Analysis News Pα+

Read more about the article Q1’25 Psychedelic Drug Development Pipeline: Bullseye Chart

Q1’25 Psychedelic Drug Development Pipeline: Bullseye Chart

Post published:January 30, 2025
Post category:2024 Year in Review Analysis

Read more about the article Pα+ Psychedelic Bulletin #186: As Trump Takes Office, Impact on Psychedelics Field Remains Unclear; The Jurvetsons Discuss Psychedelics at DLD; GH Shares PoC Data

Pα+ Psychedelic Bulletin #186: As Trump Takes Office, Impact on Psychedelics Field Remains Unclear; The Jurvetsons Discuss Psychedelics at DLD; GH Shares PoC Data

Post published:January 24, 2025
Post category:Psychedelic Bulletin Pα+

Read more about the article Bifurcation Squared: Compass Lobbies for Narrow Rescheduling in Colorado, Virginia; Pushes Back on State Policy Reforms

Bifurcation Squared: Compass Lobbies for Narrow Rescheduling in Colorado, Virginia; Pushes Back on State Policy Reforms

Post published:January 23, 2025
Post category:Analysis News

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.